Research Overview
Receptor selectivity
Ipamorelin is best known in the literature as a selectivity benchmark. Comparative studies against GHRP-6 and hexarelin reported that ipamorelin stimulated growth hormone release in animal models without the parallel increases in ACTH, cortisol and prolactin that accompanied the earlier compounds. Receptor-binding panels have been used to confirm that its activity is concentrated at GHS-R1a rather than distributed across related receptors, which makes it a cleaner probe for dissecting a single pathway.
Signal transduction
GHS-R1a is a Gq-coupled receptor: activation drives phospholipase C, inositol trisphosphate generation and intracellular calcium mobilisation in somatotrophs. Cell-based assays with ipamorelin measure calcium flux, inositol phosphate accumulation and beta-arrestin recruitment, and the receptor's unusually high constitutive activity means investigators often measure agonist effects against a substantial baseline.
Combination and comparative work
- Side-by-side profiling with GHRP-2, GHRP-6 and hexarelin to map structure–selectivity relationships within the secretagogue class
- Studies of ghrelin-receptor involvement in gastric motility and feeding behaviour in rodent models